This study is accepting new patients by invitation only

IVTCC 2.0: a Prospective Multicenter Ventricular Tachycardia Catheter Ablation Registry

a study on Cardiac Arrhythmia Tachycardia Ventricular Tachycardia Premature Ventricular Contractions Cardiomyopathy Cardiac Arrest

Summary

Location
at UC Davis UCLA UCSF
Dates
study started
study ends around
Principal Investigator
by Jason Bradfield, MD (ucla)Kalyanam Shivkumar, MD, PhD (ucla)

Description

Summary

This is a prospective multi-center international registry. The objective of this registry is to collect prospective data on patients undergoing catheter ablation for Ventricular Tachycardia (VT) and Premature Ventricular Contractions (PVC). The registry will be used for clinical monitoring, research, and quality improvement purposes.

Official Title

An International VT Ablation Center Collaborative Group (IVTCC): a Multicenter Ventricular Tachycardia Catheter Ablation Registry

Details

Sudden cardiac death (SCD), predominantly due to ventricular tachyarrhythmias, is a leading cause of mortality in the United States and around the world. Catheter ablation of ventricular arrhythmias has proven efficacious in reducing the burden of arrhythmias and reducing implantable cardiac defibrillator (ICD) shocks.

The aim of this study is to create a prospective international database registry that will allow for better assessment of the outcomes of catheter ablation of ventricular arrhythmias. The registry, with approximately 30 participating centers, will help to identify the overall success rates and associated benefits of the procedure and provide more comprehensive data on understudied populations and treatment.

Keywords

Ventricular Arrhythmia, Ventricular Tachycardia, Premature Ventricular Contraction (PVC), Cardiomyopathy, Arrhythmia, Cardiac Conduction System Disease, Sudden Cardiac Death, Implantable Cardiac Defibrillator (ICD), Ventricular Premature Complexes, Cardiomyopathies, Cardiac Arrhythmias, Death, Sudden, Cardiac

Eligibility

Inclusion Criteria:

Locations

  • University of California, Los Angeles
    Los Angeles 5368361 California 5332921 90095 United States
  • University of California, Davis
    Sacramento 5389489 California 5332921 95817 United States
  • University of California San Francisco
    San Francisco 5391959 California 5332921 94143 United States
  • Cedars-Sinai Medical Center
    Los Angeles 5368361 California 5332921 90048 United States

Lead Scientists at University of California Health

Details

Status
accepting new patients by invitation only
Start Date
Completion Date
(estimated)
Sponsor
University of California, Los Angeles
ID
NCT04520347
Study Type
Observational [Patient Registry]
Participants
Expecting 10000 study participants
Last Updated